SARGENT INVESTMENT GROUP, LLC – Taysha Gene Therapies, Inc. Transaction History
SARGENT INVESTMENT GROUP, LLC portfolio value:
$47,000
portfolio value
SARGENT INVESTMENT GROUP, LLC quarter portfolio value change:
-48.12%
quarter
Taysha Gene Therapies, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +41.90% | 7.45K shares | -19K | $1.93 | 25.24K |
| Q2 2022 | share | Increase | +66.93% | 7.13K shares | -3K | $3.72 | 17.78K |
| Q1 2022 | share | Increase | 0.00% | 10.65K shares | 69K | $6.52 | 10.65K |